Literature DB >> 19286904

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

P Emery1, R Van Vollenhoven, M Ostergaard, E Choy, B Combe, W Graninger, K Krueger, M Matucci-Cerinic, F Navarro, P van Riel, L Settas, S Steinfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19286904     DOI： 10.1136/ard.2008.100362

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  12 in total

Review 1.  Certolizumab pegol: a new biologic targeting rheumatoid arthritis.

Authors:  Aarat M Patel; Larry W Moreland
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

2.  Therapy: Guidelines in rheumatology: quo vadis?

Authors:  Arthur Kavanaugh
Journal:  Nat Rev Rheumatol       Date:  2009-08       Impact factor: 20.543

Review 3.  Treatment of rheumatoid arthritis: state of the art 2009.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

4.  Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.

Authors:  Liseth Siemons; Harald E Vonkeman; Peter M ten Klooster; Piet L C M van Riel; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2014-02-23       Impact factor: 2.980

5.  Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?

Authors:  Alejandro Balsa; Miriam García-Arias
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 6.  Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.

Authors:  Aarat M Patel; Larry W Moreland
Journal:  Drug Des Devel Ther       Date:  2010-10-01       Impact factor: 4.162

7.  Patients' access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries.

Authors:  P A Laires; F Exposto; R Mesquita; A P Martins; L Cunha-Miranda; J E Fonseca
Journal:  Eur J Health Econ       Date:  2012-09-18

8.  Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?

Authors:  Ronald F van Vollenhoven; Katerina Chatzidionysiou
Journal:  Nat Rev Rheumatol       Date:  2013-07-30       Impact factor: 20.543

9.  Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.

Authors:  An Tran-Duy; Annelies Boonen; Wietske Kievit; Piet L C M van Riel; Mart A F J van de Laar; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

10.  Rheumatoid arthritis: International disparities in access to anti-TNF therapy.

Authors:  Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2011-04       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.